Free Trial
NASDAQ:SLXN

Silexion Therapeutics (SLXN) Stock Price, News & Analysis

Silexion Therapeutics logo
$9.28 -5.66 (-37.88%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$9.28 +0.01 (+0.05%)
As of 08/1/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Silexion Therapeutics Stock (NASDAQ:SLXN)

Key Stats

Today's Range
$7.82
$11.10
50-Day Range
$9.28
$15.60
52-Week Range
$7.82
$627.75
Volume
359,370 shs
Average Volume
161,285 shs
Market Capitalization
$5.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.00
Consensus Rating
Buy

Company Overview

Receive SLXN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Silexion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

SLXN Stock News Headlines

Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live.
Silexion Therapeutics Holds Annual General Meeting
See More Headlines

SLXN Stock Analysis - Frequently Asked Questions

Silexion Therapeutics' stock was trading at $30.15 at the beginning of the year. Since then, SLXN shares have decreased by 69.2% and is now trading at $9.28.

Silexion Therapeutics Corp (NASDAQ:SLXN) released its quarterly earnings data on Tuesday, May, 13th. The company reported ($3.90) EPS for the quarter.

Silexion Therapeutics shares reverse split before market open on Sunday, July 27th 2025.The 1-15 reverse split was announced on Sunday, July 27th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, July 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of SLXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Silexion Therapeutics investors own include Arch Capital Group (ACGL), Adobe (ADBE), Analog Devices (ADI), Alnylam Pharmaceuticals (ALNY), Amgen (AMGN), AstraZeneca (AZN) and Baidu (BIDU).

Company Calendar

Last Earnings
5/13/2025
Today
8/01/2025
Next Earnings (Estimated)
8/07/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SLXN
Previous Symbol
NASDAQ:SLXN
CIK
2022416
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$75.00
Low Price Target
$75.00
Potential Upside/Downside
+708.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$16.44 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-359.62%

Debt

Debt-to-Equity Ratio
1.16
Current Ratio
3.22
Quick Ratio
3.22

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($37.31) per share
Price / Book
-0.25

Miscellaneous

Outstanding Shares
580,000
Free Float
545,000
Market Cap
$5.38 million
Optionable
N/A
Beta
0.08
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:SLXN) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners